Sponsored in Part by a Medical Educational Grant by Myovant Sciences. Content Independently developed by Contemporary OB/GYN.
Endometriosis experts describe the potential physical, social, and psychological impact the disease may have on patients lives.
Sponsored in Part by a Medical Educational Grant by Myovant Sciences. Content Independently developed by Contemporary OB/GYN.
A panel of experts provide an overview of the health complications that are associated with endometriosis.
In this interview, Michael Krychman, MD, a community-based gynecologist in Newport Beach, California, takes a look at 2022 advances within the contraceptive space, as well as looks toward the future.
Sponsored in Part by a Medical Educational Grant by Myovant Sciences. Content Independently developed by Contemporary OB/GYN.
Sawsan As-Sanie, MD, Jessica Shim, MD, Robert Taylor, MD, PhD, and Linda Giudice, MD, PhD, discuss the 3 main types of endometriosis and the commonly associated symptoms and risk factors.
Sponsored in Part by a Medical Educational Grant by Myovant Sciences. Content Independently developed by Contemporary OB/GYN.
Hugh Taylor, MD, leads a discussion with a panel of experts about the prevalence of endometriosis.
Jeff Andrews, MD, ob-gyn and vice president of Medical Affairs at BD, sits with Contemporary OB/GYN® to discuss the findings from a survey by the Harris Poll regarding HPV and cervical cancer screening.
Jenna Beckham, MD, MSPH, FACOG, and Thomas Kimble, MD, comment on unmet needs and challenges faced by patients looking for contraception.
Experts in gynecology share practical resources for patients and providers on the currently available contraceptive options.
Drs Jenna Beckham and Thomas Kimble review the benefits of newly approved contraceptive systems, such as use in women with higher BMIs and ease of access.
Jenna Beckham, MD, MSPH, FACOG, and Thomas Kimble, MD, discuss patient misconceptions around contraceptive options and the impact on adherence.
Drs Jenna Beckham and Thomas Kimble comment on hormonal patch and vaginal gel contraceptives.
Experts in gynecology review other contraception methods, including the contraceptive ring and drospirenone and estetrol tablets.
Jenna Beckham, MD, MSPH, FACOG, and Thomas Kimble, MD, provide an overview of newly approved contraceptive modalities.
Thomas Kimble, MD, reviews potential cardiovascular risks associated with some contraceptives.
Drs Jenna Beckham and Thomas Kimble discuss the safety and efficacy of contraceptives for patients with a higher body mass Index (BMI).
Thomas Kimble, MD, provides an overview of currently available hormonal contraceptive options.
Hear from David Hackney, MD, MS, maternal-fetal medicine physician at Case Western Reserve University and chair of the American College of Obstetricians and Gynecologists' Ohio chapter, as he recaps the restrictions on reproductive rights from a ground-floor perspective.
Marco Taglietti, MD, president and CEO of Scynexis, sits with Contemporary OB/GYN® to discuss the recent approval of ibrexafungerp (Brexafemme) for the reduction in incidence of recurrent vulvovaginal candidiasis.
Experts in gynecology consider the role of pharmacists and other healthcare providers in contraceptive counseling and education.
Jenna Beckham, MD, MSPH, FACOG, and Thomas Kimble, MD, highlight key points to share with a patient who has just been prescribed a contraceptive.
In this program, OBGYN experts discuss the principals of miscarriage management and hysteroscopically-guided procedures.
Drs Jenna Beckham and Thomas Kimble share their thoughts on initiating conversations surrounding contraception options with patients.
Jenna Beckham, MD, MSPH, FACOG, and Thomas Kimble, MD, provide an overview of the use of contraception methods in the US.
Michael L. Krychman, MD, and Jack D. Sobel, MD, discuss the importance of awareness and education about RVVC, particularly given the impact of symptoms on patients’ psychosocial and sexual behavior.
Michael L. Krychman, MD, and Jack D. Sobel, MD, discuss the practical challenges of access to newer, FDA-approved medications for RVVC and how the third-party reimbursement landscape may take shape in coming years.
Experts explore the availability and cost as well as other unanswered questions regarding emerging agents for the treatment of RVVC.
Michael L. Krychman, MD, and Jack D. Sobel, MD, review the mechanisms of ibrexafungerp and how it might fit in the treatment spectrum for RVVC.
Michael L. Krychman, MD, and Jack D. Sobel, MD, review the clinical implications of the recent approval of oteseconazole, which has been shown to be efficacious and well tolerated in RVVC treatment.
Hear from Kimberly Kho, MD, as she discusses her presentation at AAGL's 51st Global Congress on MIGS in Aurora, Colorado regarding alternatives to hysterectomy and uterine-preserving options for fibroids.
Hear from Kimberly Kho, MD, as she discusses her presentation at AAGL's 51st Global Congress on MIGS in Aurora, Colorado regarding alternatives to hysterectomy and uterine-preserving options for fibroids.
